Prognostic impact of diagnosis-to-ablation time on outcomes following catheter ablation in persistent atrial fibrillation and left ventricular systolic dysfunction
Heart Rhythm · 2025
DOI: 10.1016/j.hrthm.2024.09.059 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Heart Rhythm, 2025. Verfasst von Louise Segan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Baker Heart and Diabetes Institute, Melbourne, Australia; The Alfred Hospital, Melbourne, Australia; University of Melbourne, Melbourne, Australia; M…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Ventricular Dysfunction, Left, Ventricular Function, Left. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Medtronic, National Health and Medical Research Council, National Heart Foundation of Australia.
Abstract (Originalsprache)
BACKGROUND: The optimal timing of catheter ablation in individuals with atrial fibrillation (AF) and left ventricular systolic dysfunction (LVSD) remains uncertain. OBJECTIVE: We examined whether AF diagnosis to ablation time (DAT) influences outcomes following catheter ablation (CA) in patients with persistent AF (PsAF) and LVSD from the CAMERA-MRI and CAPLA randomized studies. METHODS: We evaluated clinical outcomes according to DAT < 1 year ("shorter DAT") and ≥1 year ("longer DAT"), comparing AF recurrence, AF burden, left ventricular ejection fraction (LVEF), and LV recovery (LVEF ≥ 50%) at 12 months. DAT was also compared according to the median (24 months). RESULTS: Two hundred and ten individuals with AF and LVSD were identified, with a median DAT of 24 months. Shorter DAT was associated with lower LA global and posterior wall scar (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Baker Heart and Diabetes Institute, Melbourne, Australia; The Alfred Hospital, Melbourne, Australia; University of Melbourne, Melbourne, Australia; Monash University, Melbourne Australia.
- Baker Heart and Diabetes Institute, Melbourne, Australia; The Alfred Hospital, Melbourne, Australia; University of Melbourne, Melbourne, Australia; Monash University, Melbourne Australia; Melbourne Private Hospital, Mel…
- Baker Heart and Diabetes Institute, Melbourne, Australia; The Alfred Hospital, Melbourne, Australia; University of Melbourne, Melbourne, Australia.
- Baker Heart and Diabetes Institute, Melbourne, Australia; The Alfred Hospital, Melbourne, Australia; University of Melbourne, Melbourne, Australia; Monash University, Melbourne Australia; St Vincent's Hospital, Melbourn…
- University of Melbourne, Melbourne, Australia; Royal Melbourne Hospital, Melbourne, Australia.
- Royal Adelaide Hospital, Adelaide, Australia.
Förderung
- Medtronic
- National Health and Medical Research Council
- National Heart Foundation of Australia
- Biosense Webster
Zitieren
APA
Segan, L., Kistler, P. M., Chieng, D., Crowley, R., William, J., Cho, K., Sugumar, H., Ling, L. H., Voskoboinik, A., Hawson, J., Morton, J. B., Lee, G., Sanders, P., Kalman, J. M., & Prabhu, S. (2025). Prognostic impact of diagnosis-to-ablation time on outcomes following catheter ablation in persistent atrial fibrillation and left ventricular systolic dysfunction. Heart Rhythm. https://doi.org/10.1016/j.hrthm.2024.09.059
Vancouver
Segan L, Kistler PM, Chieng D, Crowley R, William J, Cho K, et al. Prognostic impact of diagnosis-to-ablation time on outcomes following catheter ablation in persistent atrial fibrillation and left ventricular systolic dysfunction. Heart Rhythm. 2025. doi:10.1016/j.hrthm.2024.09.059
BibTeX
@article{Segan2025,
author = {Segan, Louise and Kistler, Peter M and Chieng, David and Crowley, Rose and William, Jeremy and Cho, Kenneth and Sugumar, Hariharan and Ling, Liang-Han and Voskoboinik, Aleksandr and Hawson, Joshua and Morton, Joseph B and Lee, Geoffrey and Sanders, Prashanthan and Kalman, Jonathan M and Prabhu, Sandeep},
title = {Prognostic impact of diagnosis-to-ablation time on outcomes following catheter ablation in persistent atrial fibrillation and left ventricular systolic dysfunction},
journal = {Heart Rhythm},
year = {2025},
doi = {10.1016/j.hrthm.2024.09.059}
}
EUVIMED